ACELLT

Welcome to the Brand page for “ACELLT”, which is offered here for Pharmaceutical and veterinary preparations, pharmaceutical preparations for treating and preventing cancer, pharmaceutical preparations for cellular therapy; diagnostic preparations for medical purposes; sanitary preparations for medical purposes;chemical, biochemical and biotechnological preparations for industrial and scientific purposes;surgical, medical, and veterinary apparatus and instruments, medical apparatus and instruments for use in cancer treatment procedures for medical purposes; medical instruments and apparatus for processing blood and other cell preparations for medical purposes; medical instruments and apparatus for medical cell processing; medical instruments and apparatus for medical cell sampling; medical instruments and apparatus for transfection of cells; medical apparatus and instruments, cell counting units for medical use; diagnostic apparatus for medical purposes, diagnostic apparatus and instruments for use in cancer treatment procedures for medical purposes; diagnostic instruments and apparatus for processing blood and other cell preparations for medical purposes; diagnostic instruments and apparatus for medical cell processing; diagnostic instruments and apparatus for medical cell sampling; diagnostic instruments and apparatus for transfection of cells; diagnostic apparatus and instruments, cell counting units for medical use; apparatus and instruments for use in cancer treatment procedures for medical purposes; replacement parts of the aforementioned goods;scientific and technological services and research and design relating thereto, in particular analysis services in the field of research, development and diagnostics, scientific research, medical research for medical applications, development of new products for others; industrial analysis and research services in the field of cancer treatment, cell processing, and cellular therapy;.

Its status is currently believed to be active. Its class is unavailable. “ACELLT” is believed to be currently owned by “APEIRON BIOLOGICS AG”.